← FDA Drug Approvals (Drugs@FDA)

LUBIPROSTONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASCENT PHARMS INC · Approved 2025-01-02

Drug application

FDA Application #

ANDA218640

Application type

Abbreviated New Drug Application (Generic)

Brand name

LUBIPROSTONE

Generic name

LUBIPROSTONE

Active ingredients

LUBIPROSTONE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

ASCENT PHARMS INC

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2025-01-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown